Pharmacogenomics Informs Cardiovascular Pharmacotherapy

Authors

Mariana Babayeva, Touro College of Pharmacy, New York, NY, USA.
Brigitte Azzi, Touro College of Pharmacy, New York, NY, USA.
Zvi G. Loewy, Touro College of Pharmacy, New York, NY, USA. Zvi.loewy@touro.edu.Follow

Author Type(s)

Faculty

DOI

10.1007/978-1-0716-2573-6_9

Journal Title

Methods in Molecular Biology

First Page

201

Last Page

240

Document Type

Article

Publication Date

1-1-2022

Department

Pathology, Microbiology and Immunology

Abstract

Precision medicine exemplifies the emergence of personalized treatment options which may benefit specific patient populations based upon their genetic makeup. Application of pharmacogenomics requires an understanding of how genetic variations impact pharmacokinetic and pharmacodynamic properties. This particular approach in pharmacotherapy is helpful because it can assist in and improve clinical decisions. Application of pharmacogenomics to cardiovascular pharmacotherapy provides for the ability of the medical provider to gain critical knowledge on a patient's response to various treatment options and risk of side effects.

Recommended Citation

Babayeva, M., Azzi, B., & Loewy, Z. G. (2022). Pharmacogenomics Informs Cardiovascular Pharmacotherapy. Methods in Molecular Biology, 2547, 201-240. https://doi.org/10.1007/978-1-0716-2573-6_9